A liquid aerosol formulation comprising at least one thermally stable active ingredient selected from the group consisting of butalbital lorazepam ipratropium baclofen morphine scopolamine pharmaceutically acceptable salts and esters thereof and derivatives thereof. The liquid formulation can include an organic solvent such as propylene glycol and one or more optional excipients. The active ingredient can be present in an amount of 0.01 to 5 weight percent and the formulation can be heated to pr...

A liquid aerosol formulation comprising at least one thermally stable active ingredient selected from the group consisting of butalbital lorazepam ipratropium baclofen morphine scopolamine pharmaceutically acceptable salts and esters thereof and derivatives thereof. The liquid formulation can include an organic solvent such as propylene glycol and one or more optional excipients. The active ingredient can be present in an amount of 0.01 to 5 weight percent and the formulation can be heated to pr...

A liquid aerosol formulation comprising at least one thermally stable active ingredient selected from the group consisting of butalbital lorazepam ipratropium baclofen morphine scopolamine pharmaceutically acceptable salts and esters thereof and derivatives thereof. The liquid formulation can include an organic solvent such as propylene glycol and one or more optional excipients. The active ingredient can be present in an amount of 0.01 to 5 weight percent and the formulation can be heated to pr...

A liquid aerosol formulation comprising at least one thermally stable active ingredient selected from the group consisting of butalbital lorazepam ipratropium baclofen morphine scopolamine pharmaceutically acceptable salts and esters thereof and derivatives thereof. The liquid formulation can include an organic solvent such as propylene glycol and one or more optional excipients. The active ingredient can be present in an amount of 0.01 to 5 weight percent and the formulation can be heated to pr...